Minimal retroviral vector system
Retroviral vector systems are used for more than three decades for applications requiring a stable genetic modification of target cells. In recent years they have proven in several clinical trials their effectiveness for the treatment of different diseases.
Further Information: PDF
GWT-TUD GmbH; FB Sächsische PatentVerwertungsAgentur (SPVA)
Phone: +49 351 25933 120
All latest news from the category: Technology Offerings
Thin-film photovoltaic technology combines efficiency and versatility
Researchers at KIT develop perovskite/CIS tandem solar cells with an efficiency of nearly 25 percent; combination of materials enables mobile applications. Stacking solar cells increases their efficiency. Working with partners…